Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Welichem Biotech Inc.
DescriptionAnti-angiogenic agent that boosts neutrophil levels
Molecular Target
Mechanism of ActionAngiogenesis inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today